Analyst ratings, especially from reputable firms like Needham, can significantly influence investor sentiment and stock prices. The reiteration of a Buy rating and a substantial price target suggests that Needham sees strong fundamentals or upcoming positive developments for Phathom Pharmaceuticals, which could lead to increased investor interest and potentially drive the stock price up in the short term.